U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT06834503) titled 'Bioequivalence Study of Clonazepam 2 Mg Tablets' on Jan. 29.
Brief Summary: Demonstrate the bioequivalence in 1 study, in fasting condition of two formulations of clonazepam 2 mg Tablets / tablets immediate release in order to establish that there are no significant pharmacokinetic differences.
Study Start Date: June 10, 2025
Study Type: INTERVENTIONAL
Condition:
Healthy
Healthy Donors
Intervention:
DRUG: Rivotril(R)
Rivotril(R) 2 mg
DRUG: Clonazepam TQ 2 mg
Test
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Centro de Atencion e Investigacion Medica
Information provided by (Responsible Party): Humberto Reynales MD MSc ...